View in EDS HTML Full Text PDF Full Text

Ibrutinib as a treatment of hematologic autoimmune disorders in patients with indolent B‐cell lymphoma.

Saved in:
Bibliographic Details
Title: Ibrutinib as a treatment of hematologic autoimmune disorders in patients with indolent B‐cell lymphoma.
Authors: Daniel, Adrien1 (AUTHOR) adrien.daniel@chru-lille.fr, Ghez, David2 (AUTHOR), Ravaiau, Camille3 (AUTHOR), Cavalieri, Doriane4 (AUTHOR), Tournilhac, Olivier4 (AUTHOR), Herbaux, Charles5 (AUTHOR), Roriz, Mélanie6 (AUTHOR), Wemeau, Mathieu7 (AUTHOR), Guillet, Stéphanie8 (AUTHOR), Bossard, Jean Baptiste9 (AUTHOR), Hélène, Demarquette10 (AUTHOR), Kaphan, Eleonore11 (AUTHOR), Caroline, Regny12 (AUTHOR), Florence, Lachenal12 (AUTHOR), Pierache, Adeline13 (AUTHOR), Michel, Marc8 (AUTHOR), Godeau, Bertrand8 (AUTHOR), Terriou, Louis14 (AUTHOR) louis.terriou@chru-lille.fr
Source: European Journal of Haematology. Dec2022, Vol. 109 Issue 6, p719-727. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:09024441
DOI:10.1111/ejh.13858